[1] Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol, 2023; 79, 516−37. doi:  10.1016/j.jhep.2023.03.017
[2] Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest, 2007; 117, 539−48. doi:  10.1172/JCI30542
[3] Friedman SL, Pinzani M. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology, 2022; 75, 473−88. doi:  10.1002/hep.32285
[4] Singh S, Allen AM, Wang Z, et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol, 2015; 13, 643-54. E9.
[5] Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology, 2017; 65, 1557−65. doi:  10.1002/hep.29085
[6] Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis, 2008; 12, 733−46. doi:  10.1016/j.cld.2008.07.007
[7] Rasmussen DN, Thiele M, Johansen S, et al. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease. J Hepatol, 2021; 75, 1017−25. doi:  10.1016/j.jhep.2021.05.037
[8] Cheng XQ, Liu WY, Tian ZW, et al. Associations of non-essential metal/metalloids and their mixture with liver function in Chinese older adults: the mediating roles of lipid profiles. Environ Pollut, 2025; 373, 126207. doi:  10.1016/j.envpol.2025.126207
[9] Barouki R, Samson M, Blanc EB, et al. The exposome and liver disease - how environmental factors affect liver health. J Hepatol, 2023; 79, 492−505. doi:  10.1016/j.jhep.2023.02.034
[10] Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol, 2018; 15, 11−20. doi:  10.1038/nrgastro.2017.109
[11] Ministry of Ecology and Environment. Opinions on further strengthening the prevention and control of heavy metal pollution. https://cwrrr.org/regulation/opinions-on-further-strengthening-the-prevention-and-control-of-heavy-metal-pollution/. [2022-03-07].
[12] Wang X, Wang B, Zhou M, et al. Systemic inflammation mediates the association of heavy metal exposures with liver injury: a study in general Chinese urban adults. J Hazard Mater, 2021; 419, 126497. doi:  10.1016/j.jhazmat.2021.126497
[13] Wan H, Jiang YQ, Yang JL, et al. Sex-specific associations of the urinary fourteen-metal mixture with NAFLD and liver fibrosis among US adults: a nationally representative study. Ecotoxicol Environ Saf, 2022; 248, 114306. doi:  10.1016/j.ecoenv.2022.114306
[14] Reja D, Makar M, Visaria A, et al. Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: a nationwide survey (NHANES 2011–2016). Ann Hepatol, 2020; 19, 404−10. doi:  10.1016/j.aohep.2020.03.006
[15] Ma N, Yip R, Lewis S, et al. Environmental exposures are important risk factors for advanced liver fibrosis in African American adults. JHEP Rep, 2023; 5, 100696. doi:  10.1016/j.jhepr.2023.100696
[16] Spaur M, Nigra AE, Sanchez TR, et al. Association of blood manganese, selenium with steatosis, fibrosis in the National Health and Nutrition Examination Survey, 2017-18. Environ Res, 2022; 213, 113647. doi:  10.1016/j.envres.2022.113647
[17] Cai JC, Jia YT, Jiang P, et al. The association between NAFLD and advanced liver fibrosis with urinary heavy metal based on the NHANES 2013-2018. 2023.
[18] Tang P, Liao Q, Tang Y, et al. Independent and combined associations of urinary metals exposure with markers of liver injury: Results from the NHANES 2013–2016. Chemosphere, 2023; 338, 139455. doi:  10.1016/j.chemosphere.2023.139455
[19] Wu YP, Feng J, Zhang YY, et al. Biological ageing mediates the associations between urinary metals and metabolic dysfunction-associated steatotic liver disease. Ecotox Environ Safe, 2025; 300, 118455. doi:  10.1016/j.ecoenv.2025.118455
[20] Nie XM, Chen Y, Chen YC, et al. Lead and cadmium exposure, higher thyroid antibodies and thyroid dysfunction in Chinese women. Environ Pollut, 2017; 230, 320−8. doi:  10.1016/j.envpol.2017.06.052
[21] Wang X, Sun X, Zhang YQ, et al. Identifying a critical window of maternal metal exposure for maternal and neonatal thyroid function in China: a cohort study. Environ Int, 2020; 139, 105696. doi:  10.1016/j.envint.2020.105696
[22] Sinha RA, Bruinstroop E, Yen PM. Actions of thyroid hormones and thyromimetics on the liver. Nat Rev Gastroenterol Hepatol, 2025; 22, 9−22. doi:  10.1038/s41575-024-00991-4
[23] Sinha RA, Yen PM. Metabolic messengers: thyroid hormones. Nat Metab, 2024; 6, 639−50. doi:  10.1038/s42255-024-00986-0
[24] Cao ZJ, Lin SB, Zhao F, et al. Cohort profile: China National Human Biomonitoring (CNHBM)—A nationally representative, prospective cohort in Chinese population. Environ Int, 2021; 146, 106252. doi:  10.1016/j.envint.2020.106252
[25] Xiao GQ, Zhu SX, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology, 2017; 66, 1486−501. doi:  10.1002/hep.29302
[26] Thiele M, Pose E, Juanola A, et al. Population screening for cirrhosis. Hepatol Commun, 2024; 8, e0512. doi:  10.1097/hc9.0000000000000512
[27] Wattacheril JJ, Abdelmalek MF, Lim JK, et al. AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review. Gastroenterology, 2023; 165, 1080−8. doi:  10.1053/j.gastro.2023.06.013
[28] Mózes FE, Lee JA, Selvaraj EA, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut, 2022; 71, 1006−19. doi:  10.1136/gutjnl-2021-324243
[29] European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol, 2024; 81, 492−542. doi:  10.1016/j.jhep.2024.04.031
[30] Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024). Chin J Hepatol, 2024; 32, 418−34. (In Chinese)
[31] Department of Medical Administration, National Health Commission of the People's Republic of China. Chinese guidelines for the clinical management of obesity (2024 edition). Med J Peking Union Med Coll Hosp, 2025; 16, 90−108. (In Chinese)
[32] Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. New Engl J Med, 2021; 385, 1737−49. doi:  10.1056/NEJMoa2102953
[33] Geiger SD, Xiao J, Ducatman A, et al. The association between PFOA, PFOS and serum lipid levels in adolescents. Chemosphere, 2014; 98, 78−83. doi:  10.1016/j.chemosphere.2013.10.005
[34] Discacciati A, Palazzolo MG, Park JG, et al. Estimating and presenting non-linear associations with restricted cubic splines. Int J Epidemiol, 2025; 54, dyaf088. doi:  10.1093/ije/dyaf088
[35] Schuster NA, Rijnhart JJM, Twisk JWR, et al. Modeling non-linear relationships in epidemiological data: the application and interpretation of spline models. Front Epidemiol, 2022; 2, 975380. doi:  10.3389/fepid.2022.975380
[36] Zhang CC, Wei Q, Lu LH, et al. Effects of cobalt chloride on liver oxidative damage and ferroptosis in mice. J Environ Hyg, 2023; 13, 139−43. (In Chinese)
[37] Alarifi S, Ali D, Suliman YAO, et al. Oxidative stress contributes to cobalt oxide nanoparticles-induced cytotoxicity and DNA damage in human hepatocarcinoma cells. Int J Nanomedicine, 2013; 8, 189−99. doi:  10.2147/ijn.s37924
[38] Liu YK, Xu H, Liu F, et al. Effects of serum cobalt ion concentration on the liver, kidney and heart in mice. Orthop Surg, 2010; 2, 134−40. doi:  10.1111/j.1757-7861.2010.00076.x
[39] Wang NN, Li XY, He R, et al. Mediating role of systemic immune-inflammation index between heavy metal exposure and hepatic steatosis/hepatic fibrosis: evidence from NHANES 2005-2020. Front Nutr, 2025; 12, 1566345. doi:  10.3389/fnut.2025.1566345
[40] Zhang L, Ma SJ, Sun R, et al. Cobalt exposure was associated with the risk of hepatic steatosis and advanced liver fibrosis based on a cross-sectional study from NHANES. Ecotoxicol Environ Saf, 2025; 293, 118003. doi:  10.1016/j.ecoenv.2025.118003
[41] Tvermoes BE, Paustenbach DJ, Kerger BD, et al. Review of cobalt toxicokinetics following oral dosing: Implications for health risk assessments and metal-on-metal hip implant patients. Crit Rev Toxicol, 2015; 45, 367−87. doi:  10.3109/10408444.2014.985818
[42] Finley BL, Monnot AD, Gaffney SH, et al. Dose-response relationships for blood cobalt concentrations and health effects: a review of the literature and application of a biokinetic model. J Toxicol Environ Health Part B, 2012; 15, 493−523. doi:  10.1080/10937404.2012.744287
[43] Princivalle A, Iavicoli I, Cerpelloni M, et al. Biological monitoring of cobalt in hard metal factory workers. Int Arch Occup Environ Health, 2017; 90, 243−54. doi:  10.1007/s00420-016-1190-y
[44] Li LM, Yang XB. The essential element manganese, oxidative stress, and metabolic diseases: links and interactions. Oxid Med Cell Longev, 2018; 2018, 7580707. doi:  10.1155/2018/7580707
[45] Gandhi D, Rudrashetti AP, Rajasekaran S. The impact of environmental and occupational exposures of manganese on pulmonary, hepatic, and renal functions. J Appl Toxicol, 2022; 42, 103−29. doi:  10.1002/jat.4214
[46] Chen P, Culbreth M, Aschner M. Exposure, epidemiology, and mechanism of the environmental toxicant manganese. Environ Sci Pollut Res, 2016; 23, 13802−10. doi:  10.1007/s11356-016-6687-0
[47] Chen P, Bornhorst J, Aschner M. Manganese metabolism in humans. Front Biosci, 2018; 23, 1655−79.
[48] Dhanraj P, Venter C, Bester MJ, et al. Induction of hepatic portal fibrosis, mitochondria damage, and extracellular vesicle formation in Sprague-Dawley rats exposed to copper, manganese, and mercury, alone and in combination. Ultrastruct Pathol, 2020; 44, 182−92. doi:  10.1080/01913123.2020.1731638
[49] Povey A, Chapizanis D, Gotti A, et al. Guidelines for appropriate “biomarker of exposure” selection for EWAS studies. 2015.
[50] Liu XH, Shen H, Chen MF, et al. Clinical relevance of environmental manganese exposure with liver stiffness and steatosis detected by transient elastography in adults. Environ Sci Pollut Res, 2022; 29, 16624−32. doi:  10.1007/s11356-021-17012-5
[51] Zhang D, Wu SL, Lan YQ, et al. Blood manganese and nonalcoholic fatty liver disease: a cohort-based case-control study. Chemosphere, 2022; 287, 132316. doi:  10.1016/j.chemosphere.2021.132316
[52] Liu J, Tan L, Liu ZY, et al. Blood and urine manganese exposure in non-alcoholic fatty liver disease and advanced liver fibrosis: an observational study. Environ Sci Pollut Res, 2023; 30, 22222−31. doi:  10.1007/s11356-022-23630-4
[53] Chen J, Wu SH, Guo XJ, et al. Research progress on toxicity and detection methods of tin and inorganic tin compounds. J Environ Occup Med, 2016; 33, 65−8. (In Chinese)
[54] Ilyas S, Hutahaean S, Cahaya Situmorang P. Analysis of cytochrome c expression on liver histology of hepatitis rats after administration of tin and olive leaf ethanol extract. Pak J Biol Sci, 2022; 25, 835−42. doi:  10.3923/pjbs.2022.835.842
[55] Li L, Li H, Shi L, et al. Tin porphyrin-based nanozymes with unprecedented superoxide dismutase-mimicking activities. Langmuir, 2022; 38, 7272−9. doi:  10.1021/acs.langmuir.2c00778
[56] Brent GA. Mechanisms of thyroid hormone action. J Clin Invest, 2012; 122, 3035−43. doi:  10.1172/JCI60047
[57] Wejaphikul K, Groeneweg S, Hilhorst-Hofstee Y, et al. Insight into molecular determinants of T3 vs T4 recognition from mutations in thyroid hormone receptor α and β. J Clin Endocrinol Metab, 2019; 104, 3491−500. doi:  10.1210/jc.2018-02794
[58] Yoshizuka M, Mori N, Hamasaki K, et al. Cadmium toxicity in the thyroid gland of pregnant rats. Exp Mol Pathol, 1991; 55, 97−104. doi:  10.1016/0014-4800(91)90021-O
[59] Sun YL, Li YW, Liu ZH, et al. Environmentally relevant concentrations of mercury exposure alter thyroid hormone levels and gene expression in the hypothalamic–pituitary–thyroid axis of zebrafish larvae. Fish Physiol Biochem, 2018; 44, 1175−83. doi:  10.1007/s10695-018-0504-2
[60] He WW, Huang CX, Wang LY, et al. The correlation between triiodothyronine and the severity of liver fibrosis. BMC Endocr Disord, 2022; 22, 313. doi:  10.1186/s12902-022-01228-8
[61] Zhou J, Tripathi M, Ho JP, et al. Thyroid hormone decreases hepatic steatosis, inflammation, and fibrosis in a dietary mouse model of nonalcoholic steatohepatitis. Thyroid, 2022; 32, 725−38. doi:  10.1089/thy.2021.0621
[62] Dong X, Yang HM, Li C, et al. Triiodothyronine alleviates alcoholic liver disease injury through the negative regulation of the NLRP3 signaling pathway. Exp Ther Med, 2018; 16, 1866−72.
[63] Luo RL, Li SQ, Yang ML, et al. Mechanism of triiodothyronine alleviating acute alcoholic liver injury and delaying alcoholic liver fibrosis progression. Hum Exp Toxicol, 2025; 44, 09603271251332505.
[64] Gade M, Comfort N, Re DB. Sex-specific neurotoxic effects of heavy metal pollutants: epidemiological, experimental evidence and candidate mechanisms. Environ Res, 2021; 201, 111558. doi:  10.1016/j.envres.2021.111558
[65] Wang SY, Lyu Y, Ji SS, et al. Heavy metals and metalloids exposure and liver function in Chinese adults — A nationally representative cross-sectional study. Environ Res, 2024; 252, 118653. doi:  10.1016/j.envres.2024.118653
[66] Deng Q, Liu J, Li Q, et al. Interaction of occupational manganese exposure and alcohol drinking aggravates the increase of liver enzyme concentrations from a cross-sectional study in China. Environ Health, 2013; 12, 30. doi:  10.1186/1476-069X-12-30